secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2026-08-04T11:13:54+00:00
Accession:  0001628280-26-052152
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Critical Medical Q2 revenue $72.5M (+60.7% YoY); net loss $(10.5)M
-------------------------------------------------------------------------

- Revenue $72.5M, up 60.7% YoY; Clinical segment contributed $24.3M vs. zero in prior year.
- Net loss from continuing ops $(10.5)M (14.5% of revenue) vs. $(3.4)M loss a year ago.
- Adjusted EBITDA $7.9M (10.9% margin); operating cash flow $5.7M, free cash flow $2.9M.
- Completed bolt-on acquisitions of Louisville Perfusion, Heart/Lung Transplant Recovery, Ohio Valley Perfusion in Q2.
- Signed agreement to take over Statline's Transplant Center Organ Placement customer relationships over next year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/0001628280-26-052152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/srta-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-052152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer